Hutch News
Results per Page:
BRCA-mutation researcher Dr. Rosevalentine Bosire named Brave Fellow
In memory of runner Gabe Grunewald, research at Fred Hutch will inform new treatments for rare and aggressive cancers
One step closer to personalized oncology for chemo-resistant ovarian cancer
From the Paulovich Lab, Translational Science and Therapeutics Division
Big-picture approach helps identify experimental diagnostic to personalize ovarian cancer treatment
Team uses large-scale proteogenomic changes to identify which patients should look beyond standard treatment options
Una clave de la metástasis del cáncer de mama se esconde en las diminutas cavidades entre las células
Del Laboratorio Cheung, Programa de cánceres de mama y ovario, Consorcio del cáncer.
Navigating a cancer diagnosis while pregnant
Rare genetic mutation leads to cancer, treatment and vigilant screening for family
When more is better: bevacizumab treatment for patients with ovarian cancer
From the Liao Group, Breast and Ovary Cancers Research Program, Cancer Consortium
Fred Hutch study highlights racial disparities in ovarian cancer risk for women
Researchers examined risks for Black and white women with endometriosis and fibroids to understand how common medical interventions for those conditions modified the outcomes
Examining factors that may impact ovarian cancer survival disparities
From the Harris Group, Public Health Sciences Division
Genital powder use and epithelial ovarian cancer
From the Harris Group, Division of Public Health Sciences
Two pathways, one destination: promising drug combination to treat ovarian cancer
From the Kemp Lab, Human Biology Division
Closer to the clinic: Modeling ovarian cancer metastases after surgery
From the Greenberg Lab, Clinical Research Division
New regional collaborations will accelerate innovation in data-intensive medical science
Three research teams in Washington, Oregon and British Columbia receive pilot funding from Cascadia Data Alliance
Fred Hutch research a GeekWire Award finalist for Health Innovation of the Year
Other finalists include Fred Hutch spinoffs Adaptive Biotechnologies and Blaze Bioscience
Scientists show thin metal mesh loaded with T cells shrinks solid tumors
Within weeks, CAR T cells targeting ovarian cancer cleared tumors in 70% of treated mice, shows study in Nature Biomedical Engineering. (Note: Images available for media use.)
Adoptive transfer of engineered T cells prolongs survival in preclinical ovarian cancer
From the Greenberg lab, Clinical Research Division, and the Vaccine and Infectious Disease Division
Nanotech turns pro-tumor immune cells into cancer-killing triple agents
Strategy doubles survival in mice with cancer
Eight promising projects win Evergreen Fund grants to promote commercialization of research
A dozen scientists to receive up to $200K from 3-year-old Fred Hutch program
Jenny Hansen: Two-time survivor, first-time Obliterider
‘I am so thankful there are people out there who aren’t afraid of cancer, who pursue it’
Timmerman headed for the top, again, with friends
Hutch expedition to Kilimanjaro has already raised $1 million